October 26–27 | Hong Kong Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the 2026 Global Healthcare Innovation Summit (GHIS 2026) at the Grand Hyatt Hong Kong. (IMAGE)

InSilico Medicine

October 26–27 | Hong Kong Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the 2026 Global Healthcare Innovation Summit (GHIS 2026) at the Grand Hyatt Hong Kong.

Caption

On the afternoon of October 26, from 14:00 to 14:30, he will participate in a panel discussion titled "AI Pharma at an Inflection Point: Technological Innovation and Industry Transformation."

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.